Filing Details
- Accession Number:
- 0001209191-15-011582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-10 18:15:27
- Reporting Period:
- 2015-02-09
- Filing Date:
- 2015-02-10
- Accepted Time:
- 2015-02-10 18:15:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Celladon Corp | CLDN | Biological Products, (No Disgnostic Substances) (2836) | 330971591 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590703 | M Krisztina Zsebo | 11988 El Camino Real, Suite 650 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-09 | 41,302 | $1.12 | 44,427 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-02-09 | 6,629 | $8.00 | 51,056 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-09 | 41,302 | $15.85 | 9,754 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-09 | 6,629 | $15.94 | 3,125 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2015-02-09 | 41,302 | $0.00 | 41,302 | $1.12 |
| Common Stock | Stock option (right to buy) | Disposition | 2015-02-09 | 6,629 | $0.00 | 6,629 | $8.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 748,208 | 2013-01-27 | 2022-06-14 | No | 4 | M | Direct |
| 741,579 | 2015-01-29 | 2024-01-28 | No | 4 | M | Direct |
Footnotes
- The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.69 to $16.31 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.70 to $16.26 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
- 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 29, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
Billionaire Hedge Funds
